MET and cancer: The Met receptorbinds the hepatocyte growth factor ligand that, upon triggered dimerizationof the Met complexes, signals increased cell migration, proliferation,and metastasis through intracellular activation of tyrosine-kinasephosphorylation circuits. Indeed, theMet receptor has been a target of cancer therapy.